Empresa Prelude Therapeutics Incorporated
Acciones
PRLD
US74065P1012
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
3,87 USD | +0,52 % | -21,18 % | -9,37 % |
Resumen de negocios
Número de empleados: 128
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Krishna Vaddi
FOU | Founder | 58 | 01/02/16 |
Bryant Lim
DFI | Director of Finance/CFO | 53 | 01/02/23 |
Jane Huang
PSD | President | 51 | 04/04/22 |
Wan-Jen Hong
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Madhu Pudipeddi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Aimee Crombie
COO | Chief Operating Officer | - | 01/01/18 |
Peggy Scherle
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/04/18 |
Lindsey Trickett
IRC | Investor Relations Contact | - | - |
Michele Porreca
HRO | Human Resources Officer | - | 01/06/21 |
Andrew Combs
PRN | Corporate Officer/Principal | 58 | 01/04/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Julian Baker
BRD | Director/Board Member | 57 | 25/01/21 |
Paul Friedman
CHM | Chairman | 81 | 01/07/16 |
David Bonita
BRD | Director/Board Member | 48 | 01/07/16 |
Mardi Dier
BRD | Director/Board Member | 60 | 01/08/20 |
Martin Babler
BRD | Director/Board Member | 59 | 19/07/21 |
Victor Sandor
BRD | Director/Board Member | 57 | 01/05/20 |
Krishna Vaddi
FOU | Founder | 58 | 01/02/16 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 54 920 594 | 51 116 607 ( 93,07 %) | 0 | 93,07 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-9,37 % | 212 M | |
+3,13 % | 43,43 mil M | |
+48,71 % | 41,69 mil M | |
+8,49 % | 41,31 mil M | |
-10,82 % | 27,14 mil M | |
+8,26 % | 25,28 mil M | |
-23,69 % | 18,47 mil M | |
+1,58 % | 12,33 mil M | |
+32,83 % | 12,59 mil M | |
+6,63 % | 11,03 mil M |
- Bolsa de valores
- Acciones
- Acción PRLD
- Empresa Prelude Therapeutics Incorporated